Pragmatic objectivity and the standardization of engineered tissues

Social Studies of Science

Volumn 39, Issue 5, 2009, Pages 717-742

  Hogle, Linda F ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Emerging technologies; Regulation; Standardization; Tissue engineering

Indexed keywords

EID: 70349730616     PISSN: 03063127     EISSN: 14603659     Source Type: Journal    
DOI: 10.1177/0306312709103478     Document Type: Article

References (47)

1. Bodewitz, J.H.W., Henk Buurma & Gerard H. de Vries (1987) Regulatory Science and the Social Management of Trust in Medicine, in Wiebe Bijker, Thomas Hughes & Trevor Pinch (eds), The Social Construction of Technological Systems: New Directions in the Sociology and History of Technology (Cambridge, MA: MIT Press): 243-60.
2. Bowker, Geoffrey & Susan Leigh Star (1999) Sorting Things Out: Classification and its Consequences (Cambridge, MA: MIT Press).
3. Burchell, Graham, Colin Gordon & Peter Miller (eds) (1991) The Foucault Effect: Studies in Governmentality (Chicago, IL: University of Chicago Press).
4. Burger, S.R. (2003) Current Regulatory Issues in Cell and Tissue Therapy, Cytotherapy 5(4): 289-98.
5. Callon, Michel (1991) Techno-economic Networks and Irreversibility, in John Law (ed.), A Sociology of Monsters (NY: Routledge): 132-61.
6. Cambrosio, Alberto, Peter Keating, Thomas Schlich & George Weisz (2006) Regulatory Objectivity and the Generation & Management of Evidence in Medicine, Social Science and Medicine 63(1): 189-99.
7. Caplan, Arnold (2003) Design Parameters for Functional Tissue Engineering, in Farshid Guilak, David Butler, Steven Goldstein & David Mooney (eds), Functional Tissue Engineering (New York: Springer-Verlag): 129-38.
8. Chadarevian, Soraya de & Harmke Kamminga (eds) (1998) Molecularizing Biology and Medicine: New Practices and Alliances, 1920s-1970s (Amsterdam: Harwood).
9. Clarke, Adele & Theresa Montini (1993) The Many Faces of RU486: Tales of Situated Knowledges and Technological Contestations, Science, Technology, & Human Values 18(1): 42-78.
10. Daston, Lorraine (1995) The Moral Economy of Science, Osiris 10: 3-24.
11. Daston, Lorraine & Peter Galison (2007) Objectivity (New York: Zone Books).
12. Douglas, Mary (1966) Purity and Danger: An Analysis of the Concepts of Pollution and Taboo (London: Routledge & Kegan Paul).
13. Epstein, Steven (1996) Impure Science: AIDS, Activism, and the Politics of Knowledge (Berkeley, CA: University of California Press).
14. Food and Drug Administration (2006) Commisioners' Performance Report to Congress on the Office of Combination Products. Available at
15. Geertz, Clifford (1973) The Interpretation of Cultures (New York: Basic Books).
16. Gelijns, A., L. Brown, C. Magnell, E. Ronchi & A. Moskowitz (2005) Evidence, Politics and Technological Change, Health Affairs 24(1): 29-40.
17. Goldstein, Steven (2003) From Concept Toward the Clinic: Preclinical Evaluation of Tissueengineered Constructs, in Farshid Guilak, David Butler, Steven Goldstein & David Mooney (eds), Functional Tissue Engineering (New York: Springer-Verlag): 395-404.
18. Healy, Melissa (2007) From Funding to Findings: When Drug Companies Conduct Research on New Pharmaceuticals, Outcomes May be Affected - Greatly, Los Angeles Times (6 August).
19. Hilts, Philip (2003) Protecting America's Health: The FDA, Business and One Hundred Years of Regulation (New York: Alfred Knopf).
20. Hogle, Linda F. (2000) Regulating Human Tissue Innovations: Hybrid Forms of Nature and Governmentality, Science Sociale et Santé 18: 53-73.
21. Hogle, Linda F. (2007) Nodes and Modes of Action: Regenerative Medicine and Emerging Forms of Molecular Governance, unpublished manuscript, University of Wisconsin-Madison.
22. Hunziker, E., M. Spector, J. Libera, A. Getzman, S.L.-Y. Woo, et al. (2006) Translation from Research to Applications, Tissue Engineering 12(12): 3341-64.
23. Jasanoff, Sheila (1991) Acceptable Evidence in a Pluralistic Society, in Deborah Mayo & Rachelle Hollander (eds), Acceptable Evidence (New York: Oxford University Press): 29-47.
24. Jasanoff, Sheila (2005) Designs on Nature: Science and Democracy in Europe and the United States (Princeton, NJ: Princeton University Press).
25. Jorland, Gerard, Annick Opinel & George Weisz (eds) (2005) Body Counts: Medical Quantification in Historical and Sociological Perspectives (Montreal, CA: McGill-Queens University Press).
26. Keating, Peter & Alberto Cambrosio (1998) Interlaboratory Life: Regulating Flow Cytometry, in Jean-Paul Gaudillière & Ilana Löwy (eds), The Invisible Industrialist: Manufacturers and the Construction of Scientific Knowledge (New York: St Martin's Press): 250-95.
27. Keating, Peter & Alberto Cambrosio (2004) Biomedical Platforms: Realigning the Normal and the Pathological in Late Twentieth-century Medicine (Cambridge, MA: MIT Press).
28. Latour, Bruno (1987) Science in Action: How to Follow Scientists and Engineers Through Society (Cambridge, MA: Harvard University Press).
29. Law, John (2002) Aircraft Stories: Decentering the Object in Technoscience (Durham, NC: Duke University Press).
30. Law, John & Annemarie Mol (eds) (2006) Complexities: Social Studies of Knowledge Practices (Durham, NC: Duke University Press).
31. Liddell, Kathleen & Susan Wallace (2005) Emerging Regulatory Issues for Human Stem Cell Medicine, Genomics, Society & Policy 1(1): 54-73.
32. Löwy, Ilana & Jean-Paul Gaudillière (1998) Disciplining Cancer: Mice and the Practice of Genetic Purity, in Jean-Paul Gaudillière & Ilana Löwy (eds), The Invisible Industrialist: Manufacturers and the Construction of Scientific Knowledge (New York: St Martin's Press): 209-49.
33. Marks, Harry (1997) The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900-1990 (New York: Cambridge University Press).
34. Mol, Annemarie (2002) The Body Multiple: Ontology in Medical Practice (Durham, NC: Duke University Press).
35. Monroe, Douglas, Lori Potter, Mirta Millares, Anthony Barrueta & Richard Wagner (2006) Kaiser Permanente's Evaluation and Management of Biotech Drugs: Assessing, Measuring, and Affecting Use, Health Affairs 25(5): 1340-47.
36. National Partnership for Reinventing Government (1993) Report: From Red Tape to Results: Creating a Government That Works Better and Costs Less. Available at < http://govinfo.library.unt.edu/npr/index.htm> (accessed July 2008).
37. Oudshoorn, Nelly & Trevor Pinch (eds) 2003) How Users Matter: The Co-construction of Users and Technology (Cambridge, MA: MIT Press).
38. Picciolo, Grace, Kiki Hellman & Peter Johnson (1998) Tissue Engineering Medical Products Standardization: The Time is Ripe, Tissue Engineering 4(1): 5-7.
39. Plant, Anne, John T. Elliott, Alessandro Tona, Dennis McDaniel & Kurt J. Langenbach (2006) Tools for Quantitative and Validated Measurements of Cells, in D.Lansing Taylor, Jeffrey R. Haskins & Kenneth Giuliano (eds), Methods in Molecular Biology, Vol. 356: High Content Screening: A Powerful Approach to Systems Cell Biology and Drug Discovery (Totowa, NJ: Humana Press): 95-107.
40. Porter, Theodore (1995) Trust in Numbers: The Pursuit of Objectivity in Science and Public Life (Princeton, NJ: Princeton University Press).
41. Power, Michael (1997) Audit Society: Rituals of Verification (New York: Oxford University Press).
42. Riles, Annelise (ed.) (2006) Documents: Artifacts of Modern Knowledge (Ann Arbor, MI: University of Michigan Press).
43. Rose, Nikolas (1999) Powers of Freedom: Reframing Political Thought (New York: Oxford University Press).
44. Rose, Nikolas (2007) The Politics of Life Itself: Biomedicine, Power and Subjectivity in the Twenty-first Century (Princeton, NJ: Princeton University Press).
45. Schutte, Eliane, Grace L. Picciolo & David Kaplan (eds) (2004) Tissue Engineered Medical Products (TEMPS), ASTM STP 1452 (West Conshohocken, PA: ASTM).
46. Singleton, Vicky (1998) Stabilizing Instabilities: The Role of the Laboratory in the United Kingdom Cervical Screening Programme, in Marc Berg & Annemarie Mol (eds), Differences in Medicine: Unraveling Practices, Techniques & Bodies (Durham, NC: Duke University Press): 896-104.
47. Timmermans, Stefan & Marc Berg (2003) The Gold Standard: the Challenge of Evidence-based Medicine and Standardization in Health Care (Philadelphia, PA: Temple University Press).